Fujifilm Diosynth celebrates expansion in Denmark March 4, 2021 -- Contract development and manufacturing organization Fujifilm Diosynth Biotechnologies held a ceremony on March 3 to celebrate the large-scale expansion of cell culture capacity at its production facility in Hillerød, Denmark.Read More
Caribou nabs $115M to advance CRISPR-edited cell therapies March 3, 2021 -- Caribou Biosciences has completed $115 million in financing to further develop its next-generation CRISPR technology platform and advance its pipeline of allogeneic immune cell therapies for oncology.Read More
DNA Script to contribute to DARPA's mobile vaccine manufacturing platform March 2, 2021 -- DNA Script has been selected by GE Research to join a collaboration to develop a rapid response, mobile medical manufacturing platform to enable on-demand production of nucleic acid-based vaccines and therapies. The project is part of a Defense Advanced Research Projects Agency (DARPA) program.Read More
WuXi AppTec acquires Oxgene, adding to its CGT capabilities March 2, 2021 -- WuXi AppTec has completed the acquisition of Oxgene, a U.K.-based contract research and development organization that designs and develops scalable gene therapy technologies. The acquisition will allow WuXi to provide its customers with end-to-end support in the creation and development of cell and gene therapies (CGT), according to the company.Read More
Pharmaron expands CGT capabilities in U.K. March 1, 2021 -- Pharmaron has purchased Allergan Biologics for $118.7 million from AbbVie, expanding its cell and gene therapy (CGT) capabilities in the U.K.Read More